[#item_full_content] Mamedica, the UK’s leading and most-trusted provider of cannabis-based prescription medicines, today announced a £4.5 million funding round led by Casa Verde, the US-based cannabis-focused venture capital firm. Read More
[#item_full_content] Mamedica, the UK’s leading and most-trusted provider of cannabis-based prescription medicines, today announced a £4.5 million funding round led by Casa Verde, the US-based cannabis-focused venture capital firm. Read More